A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, ...
While venture capital funding dipped to its six-year low in 2025, it nevertheless remained above pre-pandemic levels for ...
The Beltway-based biopharma disputed the FDA’s conclusions regarding the data provided in its supplemental application for ...
In 2025, made or projected biopharma workforce cuts affected about 42,700 employees, according to BioSpace tallies. BioSpace ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback